InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Fallon John A., Director. Director active across 4 companies, notably COLLEGIUM PHARMACEUTICAL, INC. In total, 7 disclosures have been recorded. Activity tracked since 20 May 2021. The latest transaction was filed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Fallon John A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
15,000 shares@ US$16.49100.0% of flowCommon StockSEC:0001560152-25-000004:0
9,791 shares0Common StockSEC:0001062993-25-009810:0
7,693 shares0Common StockSEC:0001062993-24-010539:0
9,792 shares0Common StockSEC:0001062993-23-011816:0
14,035 shares0Common StockSEC:0001062993-22-013301:0
2,235 shares@ US$28.87100.0% of flowCommon StockSEC:0001127602-21-018010:0
9,941 shares0Common StockSEC:0001192482-21-000457:0
7 of 7 declarations
About Fallon John A.
John A. Fallon is a Director at Collegium Pharmaceutical, Inc., Insulet Corp, and Collegium Pharmaceutical, Inc. As a board member, he contributes to governance and strategic decision-making. His expertise in the healthcare sector is an asset for these companies.
